Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Fibrovid** is a commercially available topical antiseptic and wound-healing ointment developed by Fibroheal. It combines povidone-iodine, a polyvinylpyrrolidone-iodine complex, with silk protein. The product is positioned as a broad-spectrum wound antiseptic for skin and wound pathogens and as a wound-care biomaterial intended to support an environment conducive to wound closure and healing. Fibroheal lists its uses as common skin infections, diabetic foot ulcers, infected stasis ulcers, pressure ulcers, minor burns, cuts, scalds, lacerations, abrasions, and post-operative wounds. ([fibroheal.com](https://fibroheal.com/product/fibrovid/))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fibrovid.